Follow-up analysis of serious bacterial infections in children with fever without localising signs: How do the national institute for clinical excellence guidelines perform with the emergence of non-vaccine pneumococcal serotypes?

Archives of Disease in Childhood

Volumn 94, Issue 3, 2009, Pages 247-

  Waddle, E A ^a   Hanson, K E ^a   Jhaveri, R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BLOOD CULTURE; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; CLINICAL PRACTICE; ESCHERICHIA COLI; FEVER; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

BACTEREMIA; CHILD; FEVER OF UNKNOWN ORIGIN; HUMANS; MENINGITIS, BACTERIAL; PNEUMOCOCCAL VACCINES; PRACTICE GUIDELINES AS TOPIC; STREPTOCOCCUS PNEUMONIAE;

EID: 61449171990     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.145425     Document Type: Letter

References (4)

1. NICE. Feverish illness in children: Assessment and initial management in children younger than 5 years. London: National Institute for Health and Clinical Excellence, 2007.
2. Waddle E, Jhaveri R. Outcomes of febrile children without localizing signs post-pneumococcal conjugate vaccine. Arch Dis Child 2009;94:144-7.
3. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-54.
4. Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007;26:468-72.